New Zealand Gene Technology Bill Faces Further Delays as Scrutiny Intensifies

The New Zealand government has delayed the Gene Technology Bill for a third time, with the latest report deadline now set for October 10, 2023. Prime Minister Christopher Luxon stated that the coalition is not being obstructed by their partner, New Zealand First, but is instead taking necessary time to navigate the complexities of the legislation.

Initially, Parliament’s health committee was expected to deliver its report by July 31. This was pushed back to August 22 before the most recent extension was confirmed. The bill aims to relax New Zealand’s longstanding restrictions on gene technology, which have been in place for over 30 years, and to establish a dedicated regulatory body within the Environmental Protection Authority.

During the first reading, New Zealand First expressed support for the bill, while raising concerns about the implications of relaxing gene technology regulations. MP Mark Patterson emphasized the need for careful consideration, stating, “We must not trade away our GE-free competitive advantage lightly.” He highlighted the importance of feedback from food exporters, the organic sector, and consumers in assessing the potential risks and rewards associated with the legislation.

The bill’s introduction in December 2022 by then-science minister Judith Collins aimed to provide a regulatory pathway that ensures public and environmental safety. Collins clarified that the changes would not force the adoption of gene technologies but would create a method for those interested in pursuing them.

As discussions continue, issues regarding the bill’s potential impact on trade remain contentious. Labour’s science spokesperson, Reuben Davidson, criticized the coalition for lacking a clear consensus, suggesting that there may be internal disagreements preventing progress. Davidson remarked, “There isn’t a pathway within the coalition to support the bill,” adding that the legislation may advance too quickly without addressing critical implications.

Support for the bill is crucial, as the Labour Party, the Greens, and Te Pāti Māori all oppose the legislation, meaning that it requires the backing of all coalition parties to move forward. The coalition agreement between the National Party and New Zealand First includes a commitment to “liberalise genetic engineering laws while ensuring strong protections for human health and the environment,” while the National-ACT agreement simply states the intention to liberalize these laws.

In response to the delays, Luxon expressed confidence that New Zealand First would continue to support the bill, asserting that the government is prioritizing careful drafting over speed. “It’s just complicated work, and it’s important we get it right so we don’t make any mistakes,” he said.

As the October deadline approaches, the future of the Gene Technology Bill remains uncertain, with ongoing scrutiny from various stakeholders indicating that the discussions surrounding genetic engineering laws in New Zealand are far from settled.